Liraglutide Attenuates Endothelial Dysfunction by Inhibiting Hyperglycemia-Induced Endothelial Cell Senescence Through the LARP7/SIRT1 Pathway
By: Weili Zhong, Ying Yang and Yanru Wang
Authors
Weili Zhong
Endocrinology Department Three Wards, Harbin Medical University Affiliated Fourth Hospital, Harbin, China
Ying Yang
Endocrinology Department Three Wards, Harbin Medical University Affiliated Fourth Hospital, Harbin, China
Yanru Wang
Endocrinology Department Three Wards, Harbin Medical University Affiliated Fourth Hospital, Harbin, China
DOI: https://doi.org/10.2478/aite-2026-0006 | Journal eISSN: 1661-4917
Language: English
Submitted on: Mar 17, 2025
Accepted on: Sep 23, 2025
Published on: Dec 4, 2025
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Related subjects:
© 2025 Weili Zhong, Ying Yang, Yanru Wang, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.